Early response predicts thalidomide efficiency in patients with advanced multiple myeloma.
Waage A, Gimsing P, Juliusson G, Turesson I, Gulbrandsen N, Eriksson T, Hjorth M, Nielsen JL, Lenhoff S, Westin J, Wislöff F; Nordic Myeloma Study Group.
Waage A, et al. Among authors: gulbrandsen n.
Br J Haematol. 2004 Apr;125(2):149-55. doi: 10.1111/j.1365-2141.2004.04879.x.
Br J Haematol. 2004.
PMID: 15059136
Free article.
Clinical Trial.